For instance, pretransplant peripheral blood NKG2C+ NKG2A- NK cells could protect from CMV infection in kidney transplant recipients independently of the presence of CMV-specific T cells [88]. This evidence concerns the gene KLRC2 and cytomegalovirus infection.